Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Blood cancers, Leukaemia
Closed
Phase 3
This trial is looking at new combinations of treatment for acute lymphoblastic leukaemia (ALL). In particular, it is looking at treatments for adults between 25 and 65 years old who have recently been diagnosed with acute lymphoblastic leukaemia, and for people between 19 and 65 who have ALL with the Philadelphia chromosome.
This trial is supported by Cancer Research UK.
Recruitment start: 30 December 2010
Recruitment end: 26 July 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Adele Fielding
Cancer Research UK
Cancer Research UK & UCL Cancer Trials Unit
Chugai Pharma UK Ltd
Baxalta
Novartis Pharmaceuticals UK Ltd
NIHR Clinical Research Network: Cancer
Roche
Sigma Tau
Swedish Orphan Biovitrum
This is Cancer Research UK trial number CRUK/09/006.
We have more information on the work of Professor Adele Fielding.
Last reviewed: 15 January 2019
CRUK internal database number: 1849
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
